Healthcare Roundup – Healthcare Companies EPS beats: CorMedix, Glaukos

Published on: November 6, 2020
Author: Amy Liu

CorMedix EPS beats by $0.04, beats on revenue

CorMedix (NYSEMKT:CRMD): Q3 GAAP EPS of -$0.22 beats by $0.04.

Revenue of $0.93M (+1450.0% Y/Y) beats by $0.89M.

Shares +1.5% AH.

Glaukos EPS beats by $0.39, beats on revenue

Glaukos (NYSE:GKOS): Q3 Non-GAAP EPS of -$0.09 beats by $0.39; GAAP EPS of -$0.35 beats by $0.20.

Revenue of $64.8M (+10.8% Y/Y) beats by $11.06M.

Shares +2.7% AH.

Oyster Point Pharma EPS beats by $0.11

Oyster Point Pharma (NASDAQ:OYST): Q3 GAAP EPS of -$0.63 beats by $0.11.

Cash and cash equivalents of $214.3M.

AtriCure EPS beats by $0.23, beats on revenue

AtriCure (NASDAQ:ATRC): Q3 GAAP EPS of -$0.11 beats by $0.23.

Revenue of $54.76M (-3.3% Y/Y) beats by $5.39M.

Shares +1.7% AH.

Neovasc EPS beats by $0.02, beats on revenue

Neovasc (NASDAQ:NVCN): Q3 GAAP EPS of -$0.51 beats by $0.02.

Revenue of $0.63M (+26.0% Y/Y) beats by $0.08M.

Shares -2.1% AH.

Biotechnology Healthcare Services Life Science